Z-0153-2020 Class III Terminated
FDA device recall Z-0153-2020 was initiated by Roche Diagnostics Operations, Inc. on Sep 11, 2019 and is designated Class III. Reason for recall: Due to low Quality Control recovery and invalid Calibration. The recall status is terminated (terminated Jun 11, 2024). Affected quantity: 2,304 units.
Recall details
- Product Type
- Devices
- Report Date
- Oct 23, 2019
- Initiation Date
- Sep 11, 2019
- Termination Date
- Jun 11, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,304 units
Product description
Cobas c Bilirubin Total Gen.3 Catalog Number: 05795419190 - Product Usage: In vitro test for the quantitative determination of the total bilirubin in serum and plasma of adults and neonates on Roche/Hitachi cobas c systems.
Reason for recall
Due to low Quality Control recovery and invalid Calibration.
Distribution pattern
US Nationwide distribution including the states of AL, AZ, CA, CT, FL, GA, HI, IA, IL, IN, KY, LA, MA, MD, MI, MO, NE, NH, NJ, NY, OH, OK, PA, PR, RI, SC, TN, TX, UT, VA and WI. Updated as of 12/20/19 to include the following additional US states: CO.
Code information
Lot # 36133801
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0153-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026